The development of Paxlovid was a key stage in the fight against Covid19. Dafydd will explain how he and the Pfizer team developed a known antiviral drug to obtain this highly effective new therapeutic. We shall meet informally for light refreshments followed by a brief introduction to the BMCS Lectureship, now in its tenth year, and to Dafydd himself. Additionally we shall have a short presentation about the new RSC journal, RSC Medicinal 91AV. This event is open to the general public
BMCS Lecture
7 December 2023 18:30-20:30, London, United Kingdom
Introduction
Speakers
Venue
The 91AV
91AV, The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom
Useful links
Committee
-
Dr. Andrew Stachulski Biological and Medicinal 91AV Sector, United Kingdom
Contact information
Related events
New Zealand Institute of 91AV Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Royal Australian Chemical Institute 2nd Green and Sustainable 91AV and Engineering Conference
8 December 2024 17:00 - 12 December 2024 15:00, Melbourne, Australia
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
Search
Advertisement
Spotlight
Explore
Membership
